Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:49 PM UTC
| NCT Number | NCT05139017 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 290 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT05139017 is currently recruiting participants. This phase2 study for diffuse large b-cell lymphoma is actively seeking new participants at 26 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05139017 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05139017 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.